cancer medicine articles & resources on Made-in-China.com

AstraZeneca,DKFZ and EORTC Have Joined The Consortium.WIN Is a Unique Global Network

Feb 11, 2014

The Worldwide Innovative Network(WIN)Consortium in personalized cancer medicine is proud to announce that AstraZeneca,DKFZ and EORTC have joined the Consortium.WIN is a unique global network of leading academics,industries,payors and ...

Tags: WIN, cancer medicine, DKFZ, EORTC

Janssen-Cilag Has Submitted MAA to EMA

Nov 1, 2013

Janssen-Cilag (Janssen), a subsidiary of Johnson & Johnson pharmaceutical firm, has submitted marketing authorization application (MAA) to the European Medicines Agency (EMA) for the approval of once daily oral drug ibrutinib for the ...

Tags: Blood Cancer Medicine, Medicine

Astellas Announced The Availability of Xtandi a New Treatment for Advanced Prostate Cancer

Jul 12, 2013

Astellas Pharma has announced the availability of Xtandi (enzalutamide), a new treatment for advanced prostate cancer in patients who have failed on first-line hormonal treatments and docetaxel chemotherapy, in the UK. Administered ...

Tags: Astellas, Cancer Medication

Prometheus Is Set to Begin Phase IV Multi-Center Study of Proleukin

Jun 4, 2013

Speciality pharmaceutical and diagnostic company, Prometheus is set to begin Proclivity02, a study that compares the sequence of Proleukin (High Dose Interleukin-2 (HD IL-2) therapy at multi centers in US for metastatic melanoma (mM). ...

Tags: Health, Medicine

IBM's Watson Supercomputer Has Gone From Game Show King to Doctor's Office Helper

Feb 18, 2013

IBM's Watson supercomputer has gone from game show king to doctor's office helper. You may recall the epic man vs. machine battle two years ago in which the supercomputer beat former champions on the show Jeopardy. Well, now there's a ...

Tags: IBM, Watson supercomputer, computer market

UCL Cancer Institute Selectes RainDance ThunderStorm System to Validate Genomic

Dec 17, 2012

University College London (UCL) Cancer Institute has selected RainDance Technologies' ThunderStorm system to validate genomic and epigenomic targets of clinical and non-clinical cancer studies. The targets will be validated from studies ...

Tags: UCL, Cancer Institute, RainDance Technologies, ThunderStorm system